Immix Biopharma (IMMX) EBIT (2021 - 2026)
Quarterly results put EBIT at -$10.8 million for Q1 2026, down 130.71% from a year ago — trailing twelve months through Mar 2026 was -$36.1 million (down 65.74% YoY), and the annual figure for FY2025 was -$30.0 million, down 32.11%.
Immix Biopharma has reported EBIT over the past 6 years, most recently at -$10.8 million for Q1 2026.
- EBIT reached -$10.8 million in Q1 2026 per IMMX's latest filing, up from -$10.9 million in the prior quarter.
- Across five years, EBIT topped out at $6.5 million in Q4 2023 and bottomed at -$10.9 million in Q4 2025.
- Median EBIT over the past 5 years was -$4.7 million (2025), compared with a mean of -$4.5 million.
- The largest annual shift saw EBIT plummeted 718.38% in 2022 before it surged 270.15% in 2023.
- Over 5 years, EBIT stood at -$3.8 million in 2022, then soared by 270.15% to $6.5 million in 2023, then tumbled by 177.24% to -$5.0 million in 2024, then plummeted by 118.43% to -$10.9 million in 2025, then rose by 0.82% to -$10.8 million in 2026.
- Business Quant data shows EBIT for IMMX at -$10.8 million in Q1 2026, -$10.9 million in Q4 2025, and -$7.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 642.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | -10.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.80 Mn |
| Dec 31, 2025 | -10.89 Mn |
| Sep 30, 2025 | -7.66 Mn |
| Jun 30, 2025 | -6.72 Mn |
| Mar 31, 2025 | -4.68 Mn |
| Dec 31, 2024 | -4.99 Mn |
| Sep 30, 2024 | -7.39 Mn |
| Jun 30, 2024 | -4.70 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Dec 31, 2023 | 6.46 Mn |
| Sep 30, 2023 | -4.52 Mn |
| Jun 30, 2023 | -3.72 Mn |
| Mar 31, 2023 | -2.52 Mn |
| Dec 31, 2022 | -3.79 Mn |
| Sep 30, 2022 | -1.53 Mn |
| Jun 30, 2022 | -1.56 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -598,338.00 |
| Sep 30, 2021 | -347,991.00 |
| Jun 30, 2021 | -243,165.00 |
| Mar 31, 2021 | -162,520.00 |